Quality Improvement for Stroke Management at the Cleveland Clinic Health System
- 1 August 2005
- journal article
- Published by Elsevier in The Joint Commission Journal on Quality and Patient Safety
- Vol. 31 (8) , 447-454
- https://doi.org/10.1016/s1553-7250(05)31058-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic StrokeArchives of Neurology, 2004
- Introducing The Quality Institute of the Cleveland Clinic Health SystemAmerican Journal of Medical Quality, 2003
- Quality Improvement and Tissue-Type Plasminogen Activator for Acute Ischemic StrokeStroke, 2003
- Alteplase for strokeBMJ, 2002
- Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign * Commentary: Who pays the guideline writers? * Commentary: Thrombolysis in stroke: it works!BMJ, 2002
- Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community HospitalsStroke, 2001
- Use of Tissue-Type Plasminogen Activator for Acute Ischemic StrokeJAMA, 2000
- Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute StrokeJAMA, 2000
- Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter surveyNeurology, 1999
- Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based ApproachStroke, 1998